Inventor · disambiguated record
Lakshmi Bhagat
Also filed as: BHAGAT LAKSHMI
33 granted patents·20 pending applications·900 citations·filing 2002–2023
98Inventor score
Files withIDERA PHARMACEUTICALS INC34KANDIMALLA EKAMBAR7AGRAWAL SUDHIR5NANJING GENELEAP BIOTECHNOLOGY CO LTD3KANDIMALLA EKAMBAR R2
Top patents by PatentIndex Score
53 records- 0198US8202850B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsAGRAWAL SUDHIR·Filed 2010·Granted Jun 19, 2012·60 cites·17 claims
- 0298US7812000B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2007·Granted Oct 12, 2010·66 cites·18 claims
- 0398US7276489B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2002·Granted Oct 2, 2007·221 cites·22 claims
- 0496US9453228B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2015·Granted Sep 27, 2016·21 cites·24 claims
- 0596US8431544B1Compositions for inhibiting gene expression and uses thereofAGRAWAL SUDHIR·Filed 2010·Granted Apr 30, 2013·48 cites·16 claims
- 0696US7517862B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Apr 14, 2009·64 cites·9 claims
- 0795US7407944B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 5, 2008·56 cites·6 claims
- 0894US8426375B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Apr 23, 2013·25 cites·15 claims
- 0993US7632822B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Dec 15, 2009·17 cites·7 claims
- 1092US8399423B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseKANDIMALLA EKAMBAR·Filed 2008·Granted Mar 19, 2013·12 cites·12 claims
- 1192US8383598B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2008·Granted Feb 26, 2013·12 cites·13 claims
- 1292US8008267B2Stabilized immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 30, 2011·29 cites·16 claims
- 1392US7960362B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2008·Granted Jun 14, 2011·19 cites·6 claims
- 1492US7595305B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS·Filed 2005·Granted Sep 29, 2009·21 cites·7 claims
- 1591US8361986B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2011·Granted Jan 29, 2013·18 cites·6 claims
- 1691US7875594B2Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2008·Granted Jan 25, 2011·11 cites·7 claims
- 1791US7569554B2Synergistic treatment of cancer using immunomers in conjunction with therapeutic agentsIDERA PHARMACEUTICALS INC·Filed 2004·Granted Aug 4, 2009·23 cites·2 claims
- 1891US7354907B2Short immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2003·Granted Apr 8, 2008·38 cites·1 claims
- 1990US8853375B2Toll like receptor modulatorsKANDIMALLA EKAMBAR·Filed 2008·Granted Oct 7, 2014·17 cites·7 claims
- 2090US7884197B2Synthetic agonists of TLR9IDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 8, 2011·13 cites·5 claims
- 2190US7863250B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jan 4, 2011·9 cites·7 claims
- 2290US7749975B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ endsIDERA PHARMACEUTICALS INC·Filed 2005·Granted Jul 6, 2010·9 cites·8 claims
- 2389US8377898B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2007·Granted Feb 19, 2013·15 cites·13 claims
- 2489US8357665B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2006·Granted Jan 22, 2013·10 cites·15 claims
- 2589US8188261B2Stabilized immune modulatory RNA (SIMRA) compoundsKANDIMALLA EKAMBAR·Filed 2008·Granted May 29, 2012·13 cites·5 claims
- 2689US8153608B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesAGRAWAL SUDHIR·Filed 2010·Granted Apr 10, 2012·9 cites·12 claims
- 2787US7851453B2Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesIDERA PHARMACEUTICALS INC·Filed 2004·Granted Dec 14, 2010·17 cites·22 claims
- 2886US9206430B2Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2012·Granted Dec 8, 2015·7 cites·14 claims
- 2986US8946175B1Stabilized immunomodulatory oligonucleotidesKANDIMALLA EKAMBAR R·Filed 2011·Granted Feb 3, 2015·5 cites·25 claims
- 3082US8362233B2Stabilized immune modulatory RNA (SIMRA) compoundsIDERA PHARMACEUTICALS INC·Filed 2012·Granted Jan 29, 2013·5 cites·7 claims
- 3181US7851454B2Short immunomodulatory oligonucleotidesIDERA PHARMACEUTIALS INC·Filed 2007·Granted Dec 14, 2010·7 cites·8 claims
- 3279US8153777B2Modulation of toll-like receptor 5 expression by antisense oligonucleotidesKANDIMALLA EKAMBAR·Filed 2009·Granted Apr 10, 2012·3 cites·23 claims
- 3361US8153605B2Modulation of toll-like receptor 3 expression by antisense oligonucleotidesKANDIMALLA EKAMBAR·Filed 2009·Granted Apr 10, 2012·0 cites·30 claims
- 3459US2012201807A1Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotidesAGRAWAL SUDHIR·Filed 2012·Application pending·0 cites
- 3555US2017145417A1Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune responseIDERA PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 3655US2010254974A1Modulation of Immunostimulatory Properties of Oligonucleotide-Based Compounds by Optimal Presentation of 5' EndsIDERA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 3754US2022298508A1Galnac cluster phosphoramidite and targeted therapeutic nucleosidesNANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 3853US2010092486A1Modulation of myeloid differentation primary response gene 88 (myd88) expression by antisense oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3953US2010111936A1Modulation of Toll-Like Receptor 4 Expression by Antisense OligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4053US2010111935A1Modulation of Toll-Like Receptor 2 Expression By Antisense OligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4153US2010047188A1Modulation of toll-like receptor 8 expression by antisense oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4253US2023250127A1MODIFIED mRNA 5'-CAP ANALOGSNANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2022·Application pending·0 cites
- 4353US2007093439A1Short immunomodulatory oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 4452US2010035967A1Modulation of toll-like receptor 9 expression by antisense oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4552US2010041734A1Modulation of toll-like receptor 7 expression by antisense oligonucleotidesIDERA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 4650US2025171513A9A 5'-CAP ANALOG MODIFIED mRNANANJING GENELEAP BIOTECHNOLOGY CO LTD·Filed 2023·Application pending·0 cites
- 4746US2011135669A1Synthetic agonists of tlr9IDERA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4845US2008279785A1Novel synthetic agonists of toll-like receptors containing CG dinucleotide modificationsKANDIMALLA EKAMBAR R·Filed 2006·Application pending·0 cites
- 4945US2012016004A1Compositions for inhibiting gene expression and uses thereofAGRAWAL SUDHIR·Filed 2011·Application pending·0 cites
- 5044US2011009477A1Oligonucleotide-based compounds as inhibitors of toll-like receptorsIDERA PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →